It has been reported that SEPT9 is abnormally expressed in ESCC, ovarian, breast, prostate, and colorectal cancers (CRC) and acts as an oncogene or tumor suppressor gene [28, 29, 36–38]. The gene discussed is SEPTIN9; the disease is colorectal carcinoma.